WCM GI Cancer
@WCMGIcancer
The @WeillCornell Medicine (WCM) Gastrointestinal (GI) Oncology Program provides cutting-edge care for people with cancers of the digestive system.
22-06-2015 16:44:16
713 Tweets
426 Followers
46 Following
“Neoadjuvant botensilimab/balstilimab is a safe and active regimen in both pMMR/MSS and dMMR/MSI-H CRC,” said Dr. Pashtoon Kasi MD, MS re: #research he shared ASCO #GI24 evaluating a new potential treatment regimen for #ColorectalCancer bit.ly/4bhVnKp (cc: Targeted Oncology)